Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Kai W. Wucherpfennig, MD, PhD

Chair, Cancer Immunology and Virology, and Director, Center for Cancer Immunotherapy Research, Dana-Farber Cancer Institute


Kai W. Wucherpfennig, MD, PhD, is Chair of Cancer Immunology and Virology, and Director of the Center for Cancer Immunotherapy Research at Dana-Farber Cancer Institute. He is the Nancy Lurie Marks Professor of Neurology in the Field of Medical Oncology; Professor of Neurology at Brigham and Women’s Hospital and Harvard Medical School; a Professor of Immunology at Harvard Medical School; and an Associate Member of Broad Institute of MIT and Harvard.

In 1995, Dr. Wucherpfennig joined Dana-Farber, where he is principally involved in basic laboratory research that focuses on T-cell immunology and the role of T cells in cancer immunology.

Education & Training

  • 1990-1995: Research Fellowship, Department of Molecular and Cellular Biology, Harvard University
  • 1987-1990: Research Fellowship, Brigham and Women's Hospital
  • 1987: PhD, University of Goettingen, Germany
  • 1986: MD, University of Goettingen, Germany

Awards & Honors

  • 2022: Nancy Lurie Marks Professor of Neurology in the Field of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School
  • 2018: Claire W. and Richard P. Morse Research Award, Dana-Farber Cancer Institute
  • 2012: Transformative RO1, NIH Director's Transformative Research Award Program
  • 2009: Elected Fellow, American Society for the Advancement of Science
  • 2006: Elected Member of American Society for Clinical Investigation
  • 2007: Elected Member, Henry Kunkel Society, Rockefeller University
  • 1995: Langheinrich Prize, University of Berlin
  • 1992: Harry Weaver Neuroscience Scholar, National Multiple Sclerosis Society